| | Term | Count | value | Genes |
| | hsa05150: staphylococcus aureus infection | 13 | <0.001 | C3AR1, C3, HLA-DRB3, FPR1, C1R, C1S, HLA-DQA1, FCGR1A, CFH, FCGR3A, CFD, SELPLG, FCGR3B | | hsa04145: phagosome | 19 | <0.001 | MRC1, NOS1, OLR1, C3, TUBB2A, HLA-DRB3, TLR2, HLA-C, C1R, TLR6, HLA-DQA1, CYBB, CD36, FCGR1A, COMP, CLEC7A, FCGR3A, FCGR3B, THBS4 | | hsa04514: cell adhesion molecules (CAMs) | 16 | <0.001 | CLDN19, HLA-DRB3, HLA-C, L1CAM, NLGN3, CDH2, HLA-DQA1, CDH5, ALCAM, NCAM1, CD86, CD34, ITGA8, CLDN1, CD4, SELPLG | | hsa04640: hematopoietic cell lineage | 12 | <0.001 | CR1, CD37, CD36, CD34, HLA-DRB3, FCGR1A, MME, IL1B, CD4, ANPEP, CSF2RA, CSF1R | | hsa05144: malaria | 9 | <0.001 | CR1, CD36, COMP, TLR2, IL1B, HBA2, HBA1, HBB, THBS4 | | hsa04610: complement and coagulation cascades | 10 | <0.001 | C3AR1, VWF, CR1, C3, F13A1, CFH, TFPI, C1R, C1S, CFD | | hsa04510: focal adhesion | 17 | 0.0017 | PIK3CG, EGFR, CAV1, TNXB, TNC, FLNB, MYL9, VWF, CCND1, PAK3, CCND2, COMP, ITGA8, COL6A3, PDGFRA, SPP1, THBS4 | | hsa04060: cytokine-cytokine receptor interaction | 18 | 0.0022 | EGFR, CCL3, TGFBR1, LIFR, EDA2R, CCL4L1, CCL4, CXCL12, IL17RA, LEP, PPBP, CXCL14, CCL3L3, CX3CR1, PDGFRA, IL1B, CSF2RA, CSF1R | | hsa05140: leishmaniasis | 9 | 0.0027 | CR1, C3, HLA-DRB3, FCGR1A, TLR2, IL1B, FCGR3A, FCGR3B, HLA-DQA1 | | hsa04151: PI3K-akt signaling pathway | 23 | 0.0033 | EGFR, PIK3CG, FGF7, TNXB, TNC, TLR2, FGF10, IRS1, DDIT4, VWF, CCND1, LPAR5, CCND2, COMP, ITGA8, COL6A3, PDGFRA, MDM2, ANGPT1, FGF1, SPP1, THBS4, CSF1R | | hsa00350: tyrosine metabolism | 6 | 0.0063 | MAOA, AOX1, ADH1C, ADH1B, ADH1A, AOC3 | | hsa03320: PPAR signaling pathway | 8 | 0.0075 | LPL, CD36, OLR1, PLIN1, SLC27A6, FABP4, ACADL, ADIPOQ | | hsa04512: ECM-receptor interaction | 9 | 0.0094 | VWF, CD36, TNXB, COMP, TNC, ITGA8, COL6A3, SPP1, THBS4 | | hsa04620: Toll-like receptor signaling pathway | 10 | 0.0100 | PIK3CG, CD86, CCL3, CCL3L3, TLR2, CCL4L1, IL1B, TLR6, CCL4, SPP1 | | hsa05323: rheumatoid arthritis | 9 | 0.0101 | CD86, CCL3, HLA-DRB3, CCL3L3, TLR2, IL1B, ANGPT1, CXCL12, HLA-DQA1 | | hsa05218: melanoma | 8 | 0.0103 | PIK3CG, EGFR, CCND1, FGF7, PDGFRA, MDM2, FGF10, FGF1 | | hsa04015: Rap1 signaling pathway | 15 | 0.0126 | FYB, PIK3CG, EGFR, FGF7, FPR1, FGF10, APBB1IP, DOCK4, PLCB4, LPAR5, RASGRP3, PDGFRA, ANGPT1, FGF1, CSF1R | | hsa05416: viral myocarditis | 7 | 0.0126 | CAV1, CD86, CCND1, HLA-DRB3, SGCD, HLA-C, HLA-DQA1 | | hsa04730: long-term depression | 7 | 0.0160 | PLA2G4A, PLCB4, NOS1, GRIA2, LYN, GUCY1A2, GUCY1B3 | | hsa05206: microRNAs in cancer | 18 | 0.0176 | EGFR, TNXB, CYP1B1, TNC, MIRLET7F1, MIR99A, ZEB1, MIR222, MIR221, IRS1, DDIT4, NOTCH3, CCND1, CCND2, PDGFRA, MDM2, MARCKS, MIR181B2 | | hsa05152: tuberculosis | 13 | 0.0178 | MRC1, CR1, ITGAX, C3, FCGR1A, HLA-DRB3, TLR2, IL1B, CLEC7A, FCGR3A, TLR6, FCGR3B, HLA-DQA1 | | hsa05205: proteoglycans in cancer | 14 | 0.0191 | PIK3CG, EGFR, CAV1, LUM, FZD1, TLR2, DCN, FLNB, CCND1, CBLB, GPC3, RRAS2, MDM2, PTCH1 | | hsa05143: African trypanosomiasis | 5 | 0.0250 | PLCB4, IL1B, HBA2, HBA1, HBB | | hsa05332: graft-versus-host disease | 5 | 0.0250 | CD86, HLA-DRB3, IL1B, HLA-C, HLA-DQA1 | | hsa05142: Chagas disease (American trypanosomiasis) | 9 | 0.0254 | PIK3CG, CCL3, PLCB4, C3, TGFBR1, CCL3L3, TLR2, IL1B, TLR6 | | hsa05200: pathways in cancer | 22 | 0.0267 | EGFR, PIK3CG, FGF7, TGFBR1, FZD1, RUNX1T1, FGF10, CXCL12, CBLB, CCND1, PLCB4, LPAR5, RASGRP3, SLC2A1, PDGFRA, MDM2, PTCH1, PTCH2, HHIP, FGF1, CSF2RA, CSF1R | | hsa04810: regulation of actin cytoskeleton | 14 | 0.0282 | PIK3CG, EGFR, FGF7, FGF10, NCKAP1L, MYL9, ARPC1B, ITGAX, CHRM3, PAK3, ITGA8, RRAS2, PDGFRA, FGF1 | | hsa04380: osteoclast differentiation | 10 | 0.0349 | PIK3CG, CYBB, FCGR1A, TGFBR1, IL1B, FCGR3A, TREM2, FCGR3B, CSF1R, BLNK |
|
|
